- Tofacitinib Intermediate
- (1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1- amine (R)-2-hydroxy-2-phenylacetic acid salt
- 4-Chloropyrrolo[2,3-d]pyrimidine
(1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1- amine (R)-2-hydroxy-2-phenylacetic acid salt
| API Name | Tofacitinib Intermediate |
| Intermediate Name | (1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1- amine (R)-2-hydroxy-2-phenylacetic acid salt |
| CAS No. | 376608-71-8 |
| Stage | R&D |
Disclaimer
I - Products protected by patents are developed solely for the R&D purpose intended to support regulatory submissions.
II - It is within the buyer's responsibility and liability to check the patent situation of the products in the import market(s).
I - Products protected by patents are developed solely for the R&D purpose intended to support regulatory submissions.
II - It is within the buyer's responsibility and liability to check the patent situation of the products in the import market(s).
